Pyfaesthetic Together with Jmbiotech Presents a Range of Anti Aging Treatments for Indonesian Women
Jakarta, 29 July 2022 - Pyridam Farma Tbk (PYFA) through its subsidiary in the field of dermatology and aesthetics, PYFAESTHETIC presents The Pink - aging treatment in collaboration with JMBiotech to meet the needs of doctors for quality anti-aging products. The
Continuing to Expansion & Innovation, Pyridam Farma Officially Acquires PT Ethica Industri Pharmacy
Yenfrino Gunadi (Director of Pyridam Farma), Bedjo Stefanus (SVP of Pyridam Farma), Lee Yan Gwan (President Director of Pyridam Farma), dr Widjanarko Brotosaputro (Director of Pyridam Farma), Indrawati Taurus (Ex President Director of Ethica Pharmaceutical Industry), Susanti Haryanto (Ed Director
Pyridam Farma (PYFA) Presents an AI-Based Cervix Cancer Screening Tool, Cerviray A.I.
Jakarta, 15 July 2022 - Pyridam Farma (PYFA) together with AIDOT Inc. will soon present innovative healthcare products for the people of Indonesia, namely Cerviray A.I., a portable cervical cancer detection tool that can help women in early detection of
POSTPONEMENT PUBLIC EXPOSE (“PUBLIC EXPOSE”) PT PYRIDAM FARMA TBK
We, PT Pyridam Farma Tbk., (the “Company”), would like to notify the postponement on the Public Expose that is originally planned to be electronically held on Wednesday, July 20, 2022 to become as follows: Day/Date : Thursday, July 28, 2022 Time
PUBLIC EXPOSE (“PUBLIC EXPOSE”) PT PYRIDAM FARMA TBK
The Board of Directors of PT Pyridam Farma Tbk., (hereinafter referred to as the “Company”) domiciled in South Jakarta, hereby invites the shareholders to attend the Electronic Public Expose (“Public Expose”) of the Company which will be held on: Day/Date
More Expansion! PT Pyridam Farma Tbk (PYFA) Acquisition of PT Ethica Industri Pharmaceuticals
Jakarta, 13 June 2022 - After successfully acquiring PT Holi Pharma at the end of 2021, this time PT Pyridam Farma Tbk with the issuer code PYFA again signed an agreement with companies that are part of the Fresenius Kabi
Sales of Pyridam Farma Tbk and its subsidiaries (PYFA Group) Increase 127% to Rp. 630.5 Billion in 2021
Jakarta, May 6, 2022 - PT Pyridam Farma Tbk. and its subsidiary (PYFA Group) recorded a significant increase in net sales, which increased by 127% to Rp. 630.5 Billion in 2021 compared to Rp. 277.4 billion in 2020. This increase
Mundipharma Healthcare Indonesia Appoints Pyridam Farma to Market Betadine Brand in Indonesia
Jakarta, April 5, 2022 - Mundipharma Healthcare Indonesia (MHI), the owner of the Betadine brand in Indonesia, has signed an exclusive cooperation agreement for marketing and promotion services with PT Pyridam Farma Tbk, a public pharmaceutical company in Indonesia with
Merz Therapeutics GmbH Together with Pyridam Farma Presents Innovative Products for the Indonesian Community
Jakarta, 22 March 2022 - Merz Therapeutics GmbH, an affiliate of Merz Pharmaceutical GmbH which excels in neurotoxin field with Pyridam Farma as one of the public Healthcare companies in Indonesia, announced that together they will launch an innovator product
PT Pyridam Farma Tbk Enters into a Marketing and Promotion Services Agreement with Mundhipharma Healthcare Indonesia
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company and Annex to Regulation I-E of Decree of the Board of Directors of PT Bursa Efek No. Kep. 00015/BEI/01-2021 on